Conjunctivitis: all 361 studies

Page 1 of 4. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the EyeRecruitingNCT07634913
• Efficacy of Fusidic Acid 1% in the Treatment of Bacterial ConjunctivitisRecruitingNCT06911424Phase 3
• Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure Chamber-a Randomized Placebo-controlled Double-blind StudyRecruitingNCT06778213Phase 4
• THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMICRecruitingNCT06771908
• Investigating Epstein-Barr Virus Associated ConjunctivitisEnrolling by invitationNCT06689397
• Evaluation of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06686472Phase 2
• Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic SubjectsNot yet recruitingNCT06459219
• A Study of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06153342Phase 2
• The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic ConjunctivitisEnrolling by invitationNCT05839938Not applicable
• Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen ExtractNot yet recruitingNCT05641272Phase 2/3
• Treatment of Ligneous Conjunctivitis in Children With Plasminogen DeficiencyRecruitingNCT05404932Not applicable
• Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/RhinoconjunctivitisNot yet recruitingNCT05400811Phase 3
• Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.RecruitingNCT04898283Phase 3
• Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient PopulationAvailableNCT04586062
• Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesRecruitingNCT04435990Phase 3
• Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentRecruitingNCT04276623
• Allogenic Plasma Aliquots in the Treatment of Ligneous ConjunctivitisEnrolling by invitationNCT04275232Phase 3
• Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy SubjectsCompletedNCT06363292Phase 1Results posted
• A Study Evaluating the Safety of the Nasal PumpTerminatedNCT06329687Phase 4Results posted
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 3Results posted
• Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass PollenCompletedNCT05540717Phase 3Results posted
• Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult ParticipantsCompletedNCT05430919Phase 2Results posted
• The Efficacy Of SCH1 In The Treatment Of Acute Infectious ConjunctivitisCompletedNCT05356793Phase 2Results posted
• Baricitinib for the Treatment of Ocular Mucous Membrane PemphigoidTerminatedNCT05263505Phase 2Results posted
• A Study in Adults With Grass Pollen-induced RhinoconjunctivitisCompletedNCT04881461Phase 3Results posted
• The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye AppearanceCompletedNCT04831047Phase 4Results posted
• Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic RhinitisCompletedNCT04709575Phase 3Results posted
• The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.CompletedNCT04207736Phase 3Results posted
• A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic ConjunctivitisCompletedNCT04050865Phase 3Results posted
• Topical rVA576 for Treatment of Atopic KeratoconjunctivitisTerminatedNCT04037891Phase 1/2Results posted
• Viral Conjunctivitis Treatment StudyTerminatedNCT03861728Not applicableResults posted
• A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure ChamberCompletedNCT03709121Phase 1/2Results posted
• Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.TerminatedNCT03696342Phase 3Results posted
• Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy StudyCompletedNCT03682965Phase 2Results posted
• A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic ConjunctivitisCompletedNCT03660878Phase 1/2Results posted
• Safety and Efficacy of KPI-121 in Subjects With DEDCompletedNCT03616899Phase 3Results posted
• Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy SubjectsCompletedNCT03519516Phase 1Results posted
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisCompletedNCT03494504Phase 3Results posted
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehicleCompletedNCT03489941Phase 3Results posted
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.CompletedNCT03479307Phase 3Results posted
• Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic ConjunctivitisCompletedNCT03320434Phase 2Results posted
• A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® ModelCompletedNCT03231969Phase 2Results posted
• A Study of ADX-102 in Subjects With Allergic ConjunctivitisCompletedNCT03012165Phase 2Results posted
• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and PlaceboCompletedNCT03004924Phase 3Results posted
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to PlaceboTerminatedNCT02998554Phase 3Results posted
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and PlaceboTerminatedNCT02998541Phase 3Results posted
• OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02988882Phase 3Results posted
• Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)CompletedNCT02980523Phase 2Results posted
• Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic ConjunctivitisCompletedNCT02978183Phase 2Results posted
• A Safety and Activity Study of NS2 in Subjects With Allergic ConjunctivitisCompletedNCT02578914Phase 2Results posted
• Reducing Adenoviral Patient Infected DaysCompletedNCT02472223Not applicableResults posted
• OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02445326Phase 3Results posted
• Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial ConjunctivitisCompletedNCT02432807Phase 3Results posted
• Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese SubjectsCompletedNCT02322216Phase 3Results posted
• A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal MicroscopyCompletedNCT02308501Phase 4Results posted
• Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in JapanCompletedNCT02251613Phase 4Results posted
• AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic ConjunctivitisCompletedNCT02161146Phase 3Results posted
• Phase II HDM-SPIRE Safety and Efficacy StudyCompletedNCT02150343Phase 2Results posted
• A Multi-Center Study Evaluating the Safety of AC-170 0.24%CompletedNCT02132169Phase 3Results posted
• AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic ConjunctivitisCompletedNCT02082262Phase 3Results posted
• Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic ConjunctivitisCompletedNCT02079649Phase 2Results posted
• OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02062905Phase 2Results posted
• Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in KoreaCompletedNCT01987765Results posted
• Paediatric Safety Study in Cat-PADCompletedNCT01921257Phase 2Results posted
• A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to VehicleCompletedNCT01881113Phase 3Results posted
• MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)CompletedNCT01852825Phase 1Results posted
• AGN-229666 for the Treatment of Allergic ConjunctivitisCompletedNCT01754766Phase 2Results posted
• Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01743027Phase 3Results posted
• Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial ConjunctivitisTerminatedNCT01740388Phase 3Results posted
• A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic ConjunctivitisCompletedNCT01732757Phase 4Results posted
• Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge ModelCompletedNCT01730872Phase 4Results posted
• A Six-Week Safety Study of an Investigational Ophthalmic SolutionCompletedNCT01698814Phase 3Results posted
• Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis PatientsCompletedNCT01697969Phase 4Results posted
• A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to VehicleCompletedNCT01685242Phase 3Results posted
• Phase III Cat-PAD StudyCompletedNCT01620762Phase 3Results posted
• An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese PatientsCompletedNCT01573910Phase 3Results posted
• Non-Pharmaceutical Treatment of Seasonal Allergic ConjunctivitisCompletedNCT01569191Phase 4Results posted
• Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum PratenseCompletedNCT01567306Phase 2Results posted
• Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis PatientsCompletedNCT01554956Phase 2/3Results posted
• A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)CompletedNCT01551056Phase 3Results posted
• A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)CompletedNCT01535118Results posted
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01534195Phase 4Results posted
• Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)CompletedNCT01489020Phase 1Results posted
• Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01479374Phase 3Results posted
• A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic ConjunctivitisCompletedNCT01470118Phase 4Results posted
• Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic ConjunctivitisCompletedNCT01443442Phase 4Results posted
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to PlaceboCompletedNCT01439815Phase 4Results posted
• Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)CompletedNCT01435460Phase 3Results posted
• A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)CompletedNCT01385371Phase 3Results posted
• A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01363713Phase 3Results posted
• Study of DE-114 Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01363700Phase 3Results posted
• The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid LayerCompletedNCT01346371Phase 4Results posted
• Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01332188Phase 2/3Results posted
• Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial ConjunctivitisTerminatedNCT01330355Phase 3Results posted
• Effect of Different Concentrations of SPARC1102 on Allergic ConjunctivitisCompletedNCT01320553Phase 2Results posted
• Mapracorat Ophthalmic Formulation in Subjects With Allergic ConjunctivitisCompletedNCT01289431Phase 2Results posted
• Assessment of Alcon's Ocular Image Quantification SystemCompletedNCT01282138Phase 4Results posted
• The Effect of Oral Azithromycin in the Treatment of Chlamydial ConjunctivitisCompletedNCT01178762Not applicableResults posted
• Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to VehicleCompletedNCT01175590Phase 3Results posted
• Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis PatientsCompletedNCT01174823Phase 2Results posted

← Conjunctivitis overview